Office of Cancer Centers logo

FAQs | Site Map

  • Cancer Centers  
    • a Cancer Center
    • a Research Program
    • a Shared Resource
      • Skip to content
    • Benchmark Data
    • Data Table 1
    • Data Table 2
    • Data Table 3
    • Data Table 4
  • Grants & Funding  
    • Issuance of PAR-17-095
    • Outline of Changes to P30 FOA
    • Frequently Asked Questions
    • PRMS and CPDM Guidance
    • Peer Review Process
    Skip to content
    • Policy on Peer Review of DMSP
    • DSMP Review by NCI Staff
    • ICD 10
    • Data Guide v3.1
    • eData v3.1.1
    • eData Templates
    • RPPR Instructions
  • News & Events  
    • OCC Announcements  
  • Policies & Resources  
    • Peer Reviev Funding Systems
    • Cancer Center Identity Badges
    • CTSA
      • Skip to content
    • External Links:
    • NIH RePORT
    • The Cancer Control Planet
    • NCI Fact Book
    • Office of Extramural Research
    • PHS 2590
    • SF 424
    • The Cancer Control Planet
    • External Website Policy
  • About Us  
    • Meet Our Team
    • View Our History
    • Contact Us
      • Skip to content
    • Site Map
    • Keyboard Shortcuts
DT3

 Data Table 4

 Clinical Research Studies

  • Home
  • Cancer Centers
  • Benchmark Data
  • Data Table 4

Press F5 to reset the data table

Note: All values are from data submitted annually by Centers starting from 2010 to recent year.

The following table compares the number of open trials and number of patients accrued to open trials for all NCI-designated Cancer Centers combined.

  • Study Source
  • Research Category
  • Phase
  • Primary Purpose
Number of Trials and Patients Accrued categozied by Fiscal Year and Study Source
FY Study Source Open Trials Patient Accrued
FY Total Number Median Total Number Median
2013 Industry 1,114 72 5,626 278
2013 External Peer Reviewed 403 34 13,283 313
2013 Institutional 2,094 49 44,666 722
2013 National Cooperative Group 648 71 1,872 66
2013 Other/Unknown 20,072 314 909,966 1,535
2012 Industry 5,027 76 20,611 207
2012 External Peer Reviewed 2,581 36 85,077 360
2012 Institutional 6,500 70 161,280 781
2012 National Cooperative Group 7,126 122 17,289 181
2012 Other/Unknown 3,571 93 106,377 2,135
2011 Industry 5,489 86 21,340 160
2011 External Peer Reviewed 2,669 31 67,229 134
2011 Institutional 6,941 79 134,534 828
2011 National Cooperative Group 8,028 123 16,419 174
2011 Other/Unknown 1,795 39 54,301 349
2010 Industry 5,467 80 18,299 193
2010 External Peer Reviewed 2,470 26 80,663 204
2010 Institutional 6,179 58 126,171 713
2010 National Cooperative Group 7,709 115 18,903 262
2010 Other/Unknown 2,129 0 174,449 0
FY FY Total Total of Open Trials Total of Accrued Patients

It is important to note that these are not necessarily unique trials; the same trial may be open at multiple centers.


Number of Trials and Patients Accrued by Clinical Research Category categorized by Fiscal Year and Clinical Research Category
FY Research Category Open Trials Patient Accrued
FY Total Number Median Total Number Median
2013 Agent/Device 2,735 198 15,372 535
2013 Anc/Comp/Cor 706 33 10,970 574
2013 Epi/Obs/Out 1,065 49 48,513 1,546
2013 Other Intervention 447 21 15,738 1,077
2013 Unspecified 18,193 351 822,945 4,228
2012 Agent/Device 14,435 213 52,607 557
2012 Anc/Comp/Cor 3,448 43 85,991 961
2012 Epi/Obs/Out 3,330 42 156,310 1,336
2012 Other Intervention 1,048 16 25,462 301
2012 Unspecified 2,544 204 70,264 3,064
2011 Agent/Device 15,552 231 45,433 544
2011 Anc/Comp/Cor 4,179 45 78,119 514
2011 Epi/Obs/Out 3,778 41 140,861 929
2011 Other Intervention 1,384 14 29,128 122
2011 Unspecified 29 14 281 141
2010 Agent/Device 15,348 231 53,959 670
2010 Anc/Comp/Cor 3,666 40 75,848 577
2010 Epi/Obs/Out 3,609 33 247,778 1,160
2010 Other Intervention 1,299 13 40,710 101
2010 Unspecified 32 0 190 0
FY FY Total Total of Open Trials Total of Accrued Patients

It is important to note that these are not necessarily unique trials; the same trial may be open at multiple centers.

Number of Trials and Patients Accrued categorized by Fiscal Year and Phase
FY Phase Open Trials Patient Accrued
FY Total Number Median Total Number Median
2013 0 11 48
2013 I 2,707 12,540
2013 I/II 1,068 3,933
2013 II 5,676 20,009
2013 II/III 189 524
2013 III 5,020 14,989
2013 III/IV 6 237
2013 IV 76 349
2013 IV/V 2 4
2013 V 5 8
2013 Pilot/Feasibility 1,287 15,598
2013 II-III 4 0
2013 n / a 86 1,791
2013 N/A 7,543 912,019
2013 NA 65 4,665
2013 Pilot 49 1,759
2013 IIPilot 4
2013 I/IIPilot 2
2013 IB 2 26
2013 I-II 11 25
2013 1 63 182
2013 1/2 30
2013 2 90 247
2013 2/3 3
2013 3 70 214
2013 4 2 33
2013 Expanded Access 2 4
2012 0 4 1 15 2
2012 I 2,741 38 11,845 97
2012 I/II 1,057 14 4,380 30
2012 II 5,558 75 26,504 217
2012 II/III 280 3 1,070 3
2012 III 5,292 87 15,259 153
2012 III/IV 6 1 52 0
2012 IV 84 2 430 4
2012 IV/V 1 1 8 8
2012 V 4 4 13 13
2012 Pilot/Feasibility 1,270 20 16,957 119
2012 N/A 8,508 99 314,101 2,871
2011 I 2,731 40 10,266 67
2011 I/II 1,131 16 3,628 34
2011 II 5,530 77 21,657 180
2011 II/III 123 3 246 1
2011 III 5,271 92 12,000 150
2011 III/IV 3 1 10 3
2011 IV 85 2 305 1
2011 IV/V 2 2 2 2
2011 Pilot/Feasibility 1,284 17 29,589 112
2011 N/A 8,760 99 216,121 1,835
2011 I/III 2 2 0 0
2010 0 2 0 21 0
2010 I 2,526 40 14,321 97
2010 I/II 1,139 14 4,040 38
2010 II 5,663 88 20,540 204
2010 II/III 118 1 399 1
2010 III 5,093 85 17,652 209
2010 III/IV 8 0 48 0
2010 IV 92 1 576 1
2010 IV/V 1 0 3 0
2010 V 2 0 2 0
2010 Pilot/Feasibility 1,286 17 14,010 90
2010 N/A 8,024 95 346,873 3,193
FY FY Total Total of Open Trials Total of Accrued Patients

It is important to note that these are not necessarily unique trials; the same trial may be open at multiple centers.

Number of Trials and Patients Accrued categorize by Fiscal Year and Primary Purpose
FY Primary Purpose Open Trials Patient Accrued
FY Total Number Median Total Number Median
2013 Anc/Comp/Cor 176 30 3,925 289
2013 Epi/Obs/Out 295 44 18,527 963
2013 Pre 45 9 1,082 38
2013 Scr/Det/Dia 166 10 7,411 566
2013 Sup/QoL 98 7 2,095 150
2013 The 1,591 185 5,846 409
2013 N/A 21,710 327 948,455 1,363
2012 Anc/Comp/Cor 3,582 43 84,509 795
2012 Epi/Obs/Out 2,877 34 146,355 1,107
2012 Pre 360 5 15,136 35
2012 Scr/Det/Dia 1,010 11 36,892 146
2012 Sup/QoL 824 9 13,741 101
2012 The 14,172 213 47,577 474
2012 N/A 1,980 15 46,424 229
2011 Anc/Comp/Cor 4,266 47 90,144 465
2011 Epi/Obs/Out 3,247 34 101,531 658
2011 Pre 395 5 13,273 18
2011 Scr/Det/Dia 1,049 12 34,021 149
2011 Sup/QOL 897 10 12,108 46
2011 The 14,960 217 42,534 449
2011 N/A 108 4 212 0
2010 Anc/Comp/Cor 3,600 40 72,515 578
2010 Epi/Obs/Out 2,946 25 228,234 679
2010 Pre 433 5 21,407 24
2010 Scr/Det/Dia 1,039 11 27,553 151
2010 Sup/QOL 834 9 13,826 80
2010 The 14,722 218 47,703 524
2010 N/A 380 0 7,247 0
FY Total Total of Open Trials Total of Accrued Patients

It is important to note that these are not necessarily unique trials; the same trial may be open at multiple centers.

Home|Contact Us|Accessibility|FOIA

U.S. Department of Health and Human Services|National Institutes of Health|National Cancer Institute|USA.gov

NIH…Turning Discovery Into Health®

2019 - The Office Of Cancer Centers at NCI